Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-24 @ 9:23 PM
NCT ID:
NCT04117932
Eligibility Criteria:
inclusion criteria :
* patient with bullous pemphigoid
* patient aged between 18 and 90
* patient with Karnofsky Performance score \> 60%
* patient agreed to participate to the study
exclusion criteria :
* patient with allergy to corticosteroids
* patient with allergy to ustekinumab
* patient with any severe medical condition at time of inclusion including stroke, heart failure, renal failure, high blood pressure and diabetes mellitus
* malignancy \< 5 years prior to inclusion
* pregnant or nursing (lactating) women, or women of child-bearing potential
* active infection or with recent history of clinically significant infection within 4 weeks prior to inclusion
* history or presence of infection with hepatitis B or C.
* history or presence of immunodeficiency diseases, including a positive HIV (ELISA and Western blot) test result.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT04117932
Study Brief:
Protocol Section:
NCT04117932